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Abstract
Background: The constant increase of aquaculture production and wealthy seafood consumption has forced
the industry to explore alternative and more sustainable raw aquafeed materials, and plant ingredients have been
used to replace marine feedstuffs in many farmed fish. The objective of the present study was to assess whether
plant-based diets can induce changes in the intestinal mucus proteome, gut autochthonous microbiota and
disease susceptibility of fish, and whether these changes could be reversed by the addition of sodium butyrate to
the diets. Three different trials were performed using the teleostean gilthead sea bream (Sparus aurata) as model.
In a first preliminary short-term trial, fish were fed with the additive (0.8%) supplementing a basal diet with low
vegetable inclusion (D1) and then challenged with a bacteria to detect possible effects on survival. In a second
trial, fish were fed with diets with greater vegetable inclusion levels (D2, D3) and the long-term effect of sodium
butyrate at a lower dose (0.4%) added to D3 (D4 diet) was tested on the intestinal proteome and microbiome.
In a third trial, the long-term effectiveness of sodium butyrate (D4) to prevent disease outcome after an intestinal
parasite (Enteromyxum leei) challenge was tested.
Results: The results showed that opposed forces were driven by dietary plant ingredients and sodium butyrate
supplementation in fish diet. On the one hand, vegetable diets induced high parasite infection levels that provoked
drops in growth performance, decreased intestinal microbiota diversity, induced the dominance of the
Photobacterium genus, as well as altered the gut mucosal proteome suggesting detrimental effects on intestinal
function. On the other hand, butyrate addition slightly decreased cumulative mortality after bacterial challenge,
avoided growth retardation in parasitized fish, increased intestinal microbiota diversity with a higher representation
of butyrate-producing bacteria and reversed most vegetable diet-induced changes in the gut proteome.
Conclusions: This integrative work gives insights on the pleiotropic effects of a dietary additive on the restoration
of intestinal homeostasis and disease resilience, using a multifaceted approach.
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Background
Aquaculture is one of the fastest growing food production
industries and plays a significant role in meeting global
protein needs of humans. Indeed, it is estimated that
about one billion people worldwide rely on fish as their
primary source of animal protein, mainly in Africa and
Asia [1], while the consumption of fish is continuously
promoted for its multifaceted health benefits [2–4]. How-
ever, the use of marine resources (mainly fisheries) as the
main protein and oil ingredients in aquafeed is no longer
feasible due to the stagnation of the catches, and the
increased demand for both human food and aquafeed.
This scenario has forced the industry to explore alterna-
tive and more sustainable raw materials as aquafeed ingre-
dients [5, 6] and plant ingredients have been used to
replace marine feedstuffs at relatively high levels in many
fish species [7–11]. However, low fish meal (FM) and low
fish oil (FO) inclusion diets are often associated with poor
growth and survival, enteritis or immune suppression and
impaired quality [12–19]. Furthermore, the nutritional
value of marine farmed fish can be compromised by a low
content of ω-3 long-chain polyunsaturated fatty acids,
when low FO inclusion levels are used [20–22]. Thus, a
better understanding of the long-term physiological con-
sequences of plant-based diets or other alternative feed in-
gredients is a major issue, and there is now an increasing
interest for fish feed additives to prevent or repair adverse
effects of extreme diet formulations. In addition, the need
to find potential substitutes to antibiotics has led to the
use of other functional feed additives including probiotics,
prebiotics, synbiotics, immunostimulants, organic acids,
nucleotides and medicinal herbs for boosting aquafeeds
and safeguarding general health of aquatic animals. Some
of these substances have been found to possess beneficial
immunostimulant and stress relieving properties and their
use increases the consumer confidence in farmed fish
(reviewed in [23]).
The microbial community in the human gut exerts a
major impact on host physiological, nutritional and im-
munological processes, which expands beyond the
gastrointestinal tract to far distant organs [24]. Diet
composition is among the main external factors that can
affect the composition of the intestinal microbiota. Thus,
high-protein diet, high-fat diet, prebiotics, probiotics and
polyphenols can induce changes in some selected bacter-
ial groups. In fact, there is evidence that 57% of the gut
microbiota’s entire variation is due to dietary alterations
[25, 26]. Alterations to the gut microbiota have been ob-
served in numerous diseases, including human meta-
bolic diseases such as obesity, type 2 diabetes, irritable
bowel syndrome, Alzheimer’s disease [27] and allergic
diseases [28]. However, few studies have validated caus-
ality and the underlying mechanisms remain to be eluci-
dated [29].
A major metabolic role of the gut microbiota is the
conversion of indigestible dietary carbohydrates (pre-
dominantly resistant starch and dietary fibre) into short-
chain fatty acids (SCFAs), which mainly include acetate,
propionate, and butyrate. These microbial metabolites
are sensed by the host as a signal, and in the case of bu-
tyrate, the host responds by strengthening the epithelial
barrier, reducing inflammation, and increasing the
production of mucins and antimicrobial peptides [30].
Among the available strategies to stimulate butyrate pro-
duction in the gut are diets with large amounts of diet-
ary fibre, but this is generally not well tolerated and has
a number of gastrointestinal side effects. A second op-
tion is the delivery of prebiotic substrates that are
broken down by bacteria into smaller molecules, which
are then used by butyrate producers. The third one is
the direct administration of SCFAs, which has proved ef-
fective on the management of ulcerative colitis, Crohn’s
disease, diarrhoea and obesity, brain function and behav-
iour in clinical trials [31].
The gut microbiota of fish is considerably understudied
compared to that of humans and mammals and most
studies have used culture dependant techniques, which are
limited by the fact that many microbial species are not cul-
tivable. The recent advent of next-generation sequencing
(NGS) technologies has allowed for studying complex mi-
crobial ecosystems, and their use has led to a growing ap-
preciation of the importance of the indigenous microbiota
of fish [32, 33]. Such approaches have shown that the gut
microbiota of aquatic animals is in general more fluidic
than that of terrestrial vertebrates, is highly sensitive to
dietary changes, and is modulated by life cycle variations,
health status, farming conditions, and environmental and
ecological factors (reviewed in [34, 35]).
In fish, the effects of butyrate on gut microbiota have
been poorly explored [36, 37] and the underlying mecha-
nisms of action of butyrate remain unclear and contro-
versial. Dietary butyrate improved growth and feed
utilisation in carp [37], yet no consistent effects have
been reported in rainbow trout [38] or European sea
bass [39, 40]. In gilthead sea bream (GSB), dietary butyr-
ate resulted in a very slight improvement of growth rates
in short trials [41], whereas no changes in growth per-
formance were detected in longer trials [8]. However,
dietary butyrate reversed in GSB many potentially detri-
mental effects of extreme vegetable diet formulations,
including an intestinal inflammatory profile, imbalance
of the genes involved in mucus production, changes in
the epithelial junctions, and decreased intestinal transe-
pithelial resistance [42]. Yet other gut features have to
be explored with respect to butyrate supplementation.
The objective of the present study was to assess whether
extreme vegetable diets induced changes in the intestinal
mucus proteome, gut autochthonous microbiota and
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disease susceptibility, and whether these changes could
be reversed by the addition of sodium butyrate to the
diets. We first performed a preliminary short term trial
(T1) in which small juveniles were fed for 10 weeks
with the additive (0.8%) supplementing a basal diet with
low vegetable inclusion (D1) and then challenged with
a homologous pathogenic bacterium to detect effects
on survival. This dose of additive produced a mild in-
flammatory reaction in the intestine and pronounced
glycogen accumulation in liver [42]. Consequently, we
performed a second trial (T2) where we fed fish with
even more extreme low FM/FO diets (D2, D3) and
tested the long-term effect of sodium butyrate (D4) at a
lower dose (0.4%) on the intestinal proteome and
microbiome. In a third trial (T3), the long-term effect-
iveness of sodium butyrate (D4) to prevent disease out-
come after an intestinal parasite challenge was tested.
Methods
Trials performed and diet formulations investigated
Three feeding trials were conducted and are summarised
diagrammatically in Fig. 1. A preliminary short trial (T1)
was conducted at the facilities of the Planta Piloto de
Acuarios de Experimentación (PAE) del Servei Central
de Suport a la Investigació Experimental (SCSIE) at the
University of València (UV, Spain). Fish (n = 400) with
an initial average size of 10 g were randomly distributed
in two 600 L tanks, acclimated to the experimental
conditions (water temperature = 21 ± 0.5 °C, water
salinity = 30‰) and fed a basal diet (D1) for 3 weeks,
and then fed ad libitum for 10 weeks with two different
diets. D1 was a control diet corresponding to the 33VO
(vegetable oil) diet in Benedito-Palos et al. [43], and D2
was D1 supplemented with 0.8% of a commercial
sodium butyrate preparation (Gustor BP-70 ®Norel). This
preparation is a partially protected sodium butyrate, with
70% sodium butyrate and 30% vegetable fat. This small
amount of fat allows the active principle to be active
along the entire gastrointestinal tract.
In a second long-term trial (T2) juvenile gilthead sea
bream were acclimatised for 4 weeks to the indoor ex-
perimental facilities of the Institute of Aquaculture Torre
de la Sal (IATS-CSIC, Spain) and fed with a standard
diet (Efico YM 568 1.9 mm, BioMar). When fish reached
a body weight of 15–16 g they were allocated among 12
2500 L-tanks, where each diet had triplicated tanks (150
fish/tank) and fed for 20 months four experimental diets
formulated and produced by BioMar (Brande, Denmark),
as described in [42]. FM was added at 25% in the control
diet (D1) and at 5% in the other three diets (D2, D3,
D4). Added oil was fish oil (FO) for D1 or a blend of
VOs replacing 58% of the FO for D2 and 84% for D3
and D4. The BP-70 compound was added to D4 diet at
0.4%. All diets were isonitrogenous, isolipidic and isoe-
nergetic and met all known nutritional requirements of
GSB. For details of diet composition, see Benedito-Palos
et al. [8]. The number of fish per tank was progressively
reduced by periodical sampling, maintaining the rearing
density below 15 kg/m3. Fish were fed to visual satiety
once-twice per day, 3–6 days per week depending on
season and fish size. Body weight was determined col-
lectively every 3–6 weeks to calculate the specific growth
rate (SGR) in each period. Oxygen content of outlet
water remained higher than 75% saturation and day-
length and water temperature followed natural changes
at IATS latitude (40° 5′ N; 0° 10′ E). At month 20
(September 2014), animals were sampled for proteomic
profiling of intestinal mucus (n = 6 fish per diet group, 3
Fig. 1 Diagrammatic summary of the different gilthead sea bream feeding trials (T) showing their timing, the main features of diet composition and
the analyses performed at the end of each of them. T1 and T3 involved bacterial (Photobacterium damselae subsp. piscicida, Phdp) and parasite
(Enteromyxum leei) challenges, respectively. BP-70 refers to the sodium butyrate used to supplement the diets. I.C. stands for intracoelomic
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per each of 2 replicated tanks; a total of 24 fish) and ana-
lysis of the biodiversity of intestinal microbiota (n = 8
fish per diet group, 4 per each of 2 replicated tanks; a
total of 32 fish, pools were performed with fish originat-
ing from the same tank).
In a third feeding trial (T3), juvenile GSB (25–30 g)
were fed with diets D1, D3 and D4 for 3 months in
500 L tanks under the same water and feeding condi-
tions of T2 before the parasite challenge.
Sampling procedures and ethics statement
At the end of the trials, one day-fastened fish were
sacrificed by overexposure to the anaesthetics benzo-
caine (100 g/L, in T1) or 3-aminobenzoic acid ethyl ester
(MS-222, 0.1 g/L, in T2 and T3) and tissue samples were
obtained for microbiome, proteome and parasitological
analyses.
Procedures in trial T1 were approved by the Ethics and
Animal Welfare Committee of UV and carried out in
registered installation facilities (code ES461900001203).
Procedures of trials T2 and T3 were approved by the
Ethics and Animal Welfare Committee of IATS. They
were carried out in a registered installation facility (code
ES120330001055) in accordance with the principles pub-
lished in the European animal directive (2010/63/EU) and
Spanish laws (Royal Decree RD53/2013) for the protection
of animals used in scientific experiments. For lethal sam-
plings, the suffering of animals was kept to a minimum.
Intestinal microbiome
Sample collection
The intestinal mucus of sacrificed fish was sampled fol-
lowing the method described by Kim et al. [44]. Briefly,
the intestine from the midgut region to the hindgut re-
gion was aseptically separated from the abdominal cavity
and the contents were removed by mechanical force
with forceps. These compartments have been reported
to have the greatest microbial activity [34]. After rinsing
the evacuated gut several times with sterile PBS, the
mucus was scraped off with a sterile scalpel and col-
lected in sterile 1.5 ml tubes. Four pools per dietary
group were obtained (two pools per each replicated
tank). Each pool consisted of the intestinal mucus from
two different individuals, resulting in a total number of
16 samples for microbiome analysis. During the time
lapse from mucus sampling and DNA extraction, less
than 4 h, samples were held fresh in ice.
DNA extraction
DNA was extracted using the Master Pure Complete
DNA and RNA Purification Kit (Epicentre Biotechnolo-
gies) following the manufacturer’s instructions and add-
ing some modifications according to Carda-Diéguez et
al. [45]. The DNA concentration and quality was
determined by agarose gel electrophoresis (1% w/v agar-
ose in Tris-acetate-EDTA (TAE) buffer) and Qubit
dsDNA HS Assay Kit (Life Technologies). DNA was
stored at −20 °C until used for PCR amplification.
PCR and pyrosequencing
The first 500 bp of the 16S rRNA gene, covering the
V1 to V3 regions, were chosen for sequencing as they
provide robust and informative taxonomies for study-
ing microbial diversity [46]. 16S rRNA genes were
amplified with the universal eubacterial primers 27F
(5′-AGAGTTTGATCMTGGCTCAG-3′) and 533R
(5′-TTACCGCGGCKGCTGGCACG-3′) with an an-
nealing temperature of 52 °C and 20 cycles to minim-
ise PCR biases [47]. A secondary amplification with
equal conditions was performed using the purified
PCR product as a template when the DNA concentra-
tion was insufficient. The 27F universal primer was
modified to contain an 8 bp “tag sequence” specific
to each sample, following McKenna et al. [48].
Barcodes were different in at least two nucleotides
from each other to minimise mistakes in sample as-
signments. The Agilent High Technology Assay (Agi-
lent 2100 Expert) was used to determine the amount
and quality of DNA per sample.
PCR products were mixed in equal concentrations and
purified using the PCR Clean-up DNA Purification Kit
(Mo Bio). Samples were sequenced using the Genome
Sequencer GS Junior Series (454 Life Science, Brandford,
USA) at the Central Service Support Experimental
Research (SCSIE) (University of Valencia, Spain).
Quality filtering and taxonomic assignment of sequence reads
Quality filtering of the raw sequences was performed
using the Ribosomal Database Project (RDP) pipeline
[46]. Sequences shorter than 200 bp, as well as those
with an average quality score lower than 20 and se-
quences with more than one ambiguous base call were
removed. Quality sequences were allocated to respective
samples according to the barcode sequences at the be-
ginning of each read. Chimeras were detected using
UCHIME [49]. Taxonomic assignment of the sequences
was made using the RDP classifier [46], implemented in
the MG-RAST server database, with an 80% confidence
threshold. Sequences were clustered into operational
taxonomical units (OTUs) at 97% sequence identity.
Statistical analysis of the microbiome
Rarefaction curves were obtained by plotting the
number of observed OTUs against the number of se-
quences. When the curves approximated saturation, the
number of sequences was considered appropriate for
further analyses. The Shannon diversity index was calcu-
lated as a measure of alpha-diversity. Beta-diversity
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among samples was calculated using by Fast Unifrac
[50], and visualised using principal component analysis
(PCA). Krona analysis was used to allow for a complete
visual exploration of relative abundances within the
complex hierarchies of microbial communities [51]. The
shared and unique OTUs among the four dietary groups
were also represented by a Venn diagram. All the above
analyses were performed using the GPRO software [52]
and R statistical software (v3.3.1).
The batch of sequences from this study has been de-
posited in the Sequence Read Archive of National
Centre for Biotechnology Information under the project
identification name “BIOPROJECT ID PRJNA381135”
(from SAMN06670806 to SAMN06670821).
Intestinal mucus proteomics
The proteome of the intestinal mucus of fish fed the
four experimental diets in T2 was analysed by means of
the quantitative iTRAQ technique. This analysis was
carried out in two stages, (1) an initial analysis examin-
ing separately samples of anterior and posterior intes-
tinal segments, using in total 8 pooled diet samples
(each pool consisting of 6 individuals per each intestine
segment and diet), and (2) a second analysis of only the
anterior intestine, using individual samples from each
diet (n = 6 for each diet, a total of 24 samples).
Mucus collection
Intestines of sacrificed fish were removed and unfolded
on a sterile petri dish. The posterior end of the intestine,
including the rectum plus three times the rectum length,
was cut and locked at one end with hemostatic pliers.
With a sterile syringe, 2 ml of mucus isolation buffer
(PBS with 1% dithiothreitol, 1% sodium pyruvate, 0.6%
HEPES and 0.03% amphotericin B) was introduced
through the open end of the intestinal segment, after
which the open end was immediately locked with
hemostatic pliers. The same procedure was performed
with an anterior intestine segment of equivalent length,
placing the first pliers closely after the pyloric caeca.
After 20 min incubation at 20 °C, isolation buffer was re-
covered by puncture with a syringe and individually dis-
posed into ice-cold tubes. Each incubated intestinal
tissue was opened lengthwise and the overlaying mucus
layer softly recovered with a spatula avoiding epithelial
scrapping. Mucus samples from anterior and posterior
intestine were then centrifuged for 30 min at 13,500×g
at 4 °C, and supernatants were transferred to cryotubes
and kept at − 80 °C until further processing.
Protein digestion and iTRAQ labelling
Protein samples were precipitated with trichloroacetic acid,
washed with cold acetone and air-dried. Pellets were dis-
solved with 40 μl of 8 M urea 0.5 M tetraethylammonium
bicarbonate (TEAB) and quantified by Qubit (Invitrogen)
according to manufacturer instructions. For each 100-μg
sample, volume was adjusted up to 40 μl with 0.5 M
TEAB. Samples were then reduced with 50 mM Tris-(2-
carboxyethyl) phosphine at 37 °C for 180 min, alkylated
with 100 mM methylmethanethiosulfonate for 10 min, and
urea concentration was lowered to less than 2 M with
500 mM TEAB. Samples were then digested with 10 μg of
sequencing grade trypsin in 0.5 mM TEAB overnight at
37 °C and dried in a speed vacuum. Trypsin digested
samples were labelled for 3 h with 8-plex iTRAQ reagents
with the signature ion signals 115 to 121 Da and an
internal standard was included. Labelled samples were
dissolved with 200 μl of 7 M urea, 2 M thiourea and 1.6%
ampholites.
After iTRAQ labelling, peptides were separated by iso-
lectrofocusing (IEF) on immobilised pH gradient (IPG)
strips (13 cm, pH 3–11) with 5000 V to 25,000 Vh. After
IEF, each IPG strip was cut into 11 equal pieces and pep-
tides were extracted with 120 μl of acetonitrile (ACN)
solutions at increasing concentrations (5%, 50%, 70%,
100%) plus 0.1% trifluoroacetic acid (TFA). After con-
centration by POROS R2 (Millipore), labelled peptides
were speed vacuum-dried and adjusted to a concentra-
tion of 0.20 μg/μl in 2% ACN and 0.1% TFA.
Protein identification and quantification
iTRAQ tagged peptides from IEF fractions were analysed
with the mass spectrometer nanoESI qQTOF (5600
TripleTOF, AB SCIEX). Samples were desalted out with
0.1% TFA at 3 μl/min for 5 min with a NanoLC Column
(3 μ, C18CL, 15 cm × 75 μm), and then loaded onto an
analytical LC column (3 μ, C18CL, 25 cm × 75 μm)
equilibrated in 5% ACN and 0.1% formic acid (FA).
Elution was achieved using a linear gradient of ACN
(5% - 35%) in 0.1% FA for 90 min at a flow rate of
300 nl/min. Mass spectra were acquired in Information
Dependent Acquisition mode by TOF MS scanning
from 350 to 1250 m/z performed at spectral acquisition
time of 0.25 s, followed by product ion scanning from
100 to 1500 m/z performed at 0.075 s on the 25 most
intense charged ions. The MS data has been deposited to
the ProteomeXchange Consortium via the PRIDE partner
repository with the dataset identifier PXD006183.
Protein identification and relative quantification were
performed with the ProteinPilot software (version 5.0)
using the Paragon algorithm as the search engine. Each
MS/MS spectrum was searched against the protein data-
set expressed from CSIC Nutrigroup gilthead sea bream
transcriptomic database (http://www.nutrigroup-iats.org/
seabreamdb) [53]. Parameters considered for the search
were trypsin as the digestion enzyme and MMTS as
cysteine alkylation reagent. To minimise false positive
results, the cut-off value of Unused Protein Score for
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protein identification was set at > 1.3, corresponding to a
confident limit of 95%, and the score threshold was set
at a 5% FDR. The resulting dataset was auto bias corrected
to remove any variations due to unequal mixing during
the combining of different labelled samples. Peptides for
quantification were automatically selected by the Protein-
Pilot Pro Group algorithm. Functional analysis of identi-
fied proteins was performed by means of IPA software
(www.ingenuity.com). For each protein in the analysis, the
Uniprot accession equivalent for one of the three higher
vertebrates model species in IPA (human, rat or mouse)
was searched as previously reported for the transcriptome-
encoding proteins of gilthead sea bream [53].
Data analysis and statistics
Data on protein expression was analysed using SPSS 21.0.
Comparison of anterior and posterior intestine samples
was performed by one-way analysis of variance (ANOVA)
analysis followed by Benjamini–Hochberg multiple testing
correction. Differences among experimental diets in anter-
ior intestine individual samples were assessed by ANOVA
followed by a Student–Newman–Keuls (SNK) post hoc
test. A P value < 0.05 was considered statistically signifi-
cant. Principal component analysis (PCA) and K-means
cluster analysis of proteins with differential abundance
were performed using Genesis software (v1.7.7). Heatmaps
were constructed using R statistical software (v3.3.1).
Pathogen challenges
Bacterial challenge
At the end of the feeding period of trial T1, 60 fish per
dietary treatment (20 fish/tank, 3 replicates), which
means a total of 6 tanks, were lightly anaesthetised with
clove oil (30 ppm, Guinama, Spain), intracoelomically
injected with 0.1 ml of bacterial suspensions in
phosphate-buffered saline (PBS, pH 7.4) with 8.0 × 107
colony forming units (CFU) ml−1 [54, 55]. A low lethal
dose producing mortalities around 20% (LD20) was
chosen for the bacterial challenge with Photobacterium
damselae subsp. piscicida (Phdp) [56]. Bacterial suspen-
sions consisted of Phdp strain SK 216/12, isolated from
diseased European sea bass (Dicentrarchus labrax), cul-
tured in tryptic soy agar (TSA, Pronadisa, Madrid,
Spain) supplemented with NaCl at a final concentration
of 1% (TSA-1) and sheep blood at a final concentration
of 5% (TSAB-1), at 22 °C for 48 h.
A group of 10 fish per dietary treatment was injected
with 0.1 ml PBS, as a control of the experimental hand-
ling. Fish were fed the same diets along the post-
challenge period. After the challenge, the average water
temperature was 21 ± 1 °C and fish mortality was moni-
tored daily until no more mortalities were recorded for a
minimum of two consecutive days. Post-mortem exam-
ination was performed by standard microbiological
methods (pathogen culturing and isolation steps as
described above) to confirm the presence of Phdp. Iden-
tification of the pathogen was carried out by means of
an agglutination test with the corresponding antiserum.
Cumulative mortality (CM) was calculated per dietary
treatment using the following formula: CM = “number
of dead fish” × “initial total number of fish”−1 × 100.
Mortality percentages were subjected to an analysis of
variance, using the SPSS 19.0 software (SPSS Inc.) to de-
termine the differences among diets. A P value < 0.05
was considered statistically significant.
Parasite challenge
Recipient fish (n = 30) were tested by qPCR and hist-
ology to be free of E. leei infection before starting the ex-
perimental feeding. At the end of the feeding period of
T3, fish were distributed in 12 200 L tanks (20 fish/tank,
average weight 120 g). Four replicate tanks were allo-
cated to each diet group. After 1 week of acclimatisation,
two tanks of each diet were challenged with the intes-
tinal myxozoan parasite Enteromyxum leei and the other
two were not exposed to the parasite (control). Each diet
group continued to be fed with the same experimental
diets after parasite challenge. Parasite challenge was per-
formed by anal intubation, as previously described [57].
Briefly, each recipient fish received 0.35 ml of an inocu-
lum containing viable parasites from a single homoge-
neous batch prepared from donor infected fish. The
inoculum was maintained cold and with frequent mixing
to ensure similar viable parasite doses to each fish. Con-
trol fish were intubated with the same volume of PBS. A
non-lethal (NL) PCR was conducted 5 weeks post intub-
ation (p.i.) to verify the status of the infection in all re-
cipient D1 fish and to decide the final sampling point.
NL samples were obtained by probing the rectum with a
swab [58] and PCR diagnosis was carried out as indi-
cated in Sitjà-Bobadilla & Palenzuela [59]. Fish were
weighted and sized before the challenge, at an inter-
mediate time point (5 weeks p.i.) when checked for the
infection status, and at the last sampling (10 weeks p.i.).
Fulton’s condition factor (CF = (100 × body weight)/
length3) and SGR (100 × ln (final body weight − initial
body weight) / days)) were also calculated. Only two cas-
ualties were registered after the challenge in recipient
groups: one in D3 and one in D4. All fish were sacrificed
and intestinal samples taken 10 weeks p.i. for parasite
diagnosis by histology and qPCR.
Parasite quantification by qPCR
After necropsy, entire intestines of 12 experimental fish
per tank were removed and individually weighed. They
were then placed in stomacher bags (Stomacher® 400,
Seward), and the volume of each sample was adjusted by
eye with variable volumes of PBS (4–8 ml), depending
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on the tissue weight/volume. Samples were homoge-
nised, mesh-filtered and collected. Aliquots (500 μl)
were taken from each sample for DNA extraction. They
were centrifuged, and the pellets suspended in 200 μl of
DNA lysis buffer. DNA extraction from these samples
was performed using commercial silica-based spin col-
umns kits. Parasite rDNA gene copies in the samples
were quantified by qPCR [59]. Numbers were interpo-
lated from the cycle thresholds (Ct) of the samples using
a standard curve with known numbers of the target gene
(6–7 orders of magnitude), run in the same plates on
each assay. Only data from reactions with standard
curves within an efficiency range (E = 0.85–1.1), and
R2 > 0.99 were accepted. Two dilutions of each DNA
sample were run. Samples with Ct < 38 were considered
positive whereas samples with 38 < Ct < 40 were flagged
and repeated. In several cases, new dilutions and new
DNA extractions from additional aliquots of the original
homogenates had to be processed to reach a consensus
on the status of weakly positive or inconsistent samples.
Statistical differences between groups on prevalence, in-
tensity and abundance data were analysed by Fisher’s
exact test, one-way ANOVA or Kruskal–Wallis tests
followed by Tukey’s or Dunn’s multiple comparison tests
(significance was considered when P < 0.05).
Parasite evaluation by histology
After necropsy, anterior, middle and posterior intestinal
segments of 5 fish from each tank (different from those
used for qPCR) were fixed in 10% buffered formalin,
dehydrated in a graded ethanol series, embedded in par-
affin, 4-μm sectioned and stained with Giemsa. Parasito-
logical evaluation was done by the observation of all the
microscopic fields of the three intestinal segments by
the same observer in a blind mode. The intensity of the
infection by E. leei was semi-quantitatively evaluated in
a scale ranging from 1 (very low) to 6 (very high), and
the type of parasitic stages registered. The parasite was
not detected in any control fish. The prevalence of infec-
tion and the mean intensity of infection for each of in-
testinal segment were calculated. The possible
dependence between the prevalence of infection and the
diet group for each intestinal segment was analysed by
chi-square with Yates’-correction (significance was con-
sidered when P < 0.05).
Results
Diet induced changes on the intestinal microbiome
Microbial communities present in the intestinal mucus
(autochthonous or resident microbiota) of fish fed differ-
ent experimental diets in T2 were analysed. A total of
143,283 quality reads were obtained, ranging from 2985
to 11,906 reads per sample, and with an average of 8955.
Reads were clustered and assigned to OTUs, and were
predominantly classified to the phylum Proteobacteria.
Since rarefaction curves approximated saturation (hori-
zontal asymptote), a good coverage of the bacterial com-
munity was achieved and the number of sequences for
analysis was considered appropriate (Additional file 1:
Figure S1). Rarefaction analysis and the Shannon index
was used to examine alpha-diversity and showed that
microbiota from fish fed control diet (D1) was more di-
verse than fish fed experimental D2 and D3 diets, but
less than those fed D4 diet. Thus, the diet supplemented
with butyrate showed the highest diversity (Table 1).
Forty-six OTUs (species/genus level) were shared
among all samples, mainly consisting of members of the
phylum Proteobacteria (60%), Bacteroidetes (17.4%) and
Firmicutes (8.7%) (Fig. 2a and Additional file 2: Table S1).
The phylum Proteobacteria dominated the intestinal
microbiota in D1 (93%), D2 (93%) and D3 (87%) groups.
However, this proportion decreased to 62% in fish fed D4
diet, while increasing the presence of Firmicutes, Fusobac-
teria and Bacteroidetes phyla (18, 10 and 7%, respectively)
(Fig. 2b and Additional file 2: Table S1). Vibrionaceae was
the dominant family in all diet groups, constituting 93.4,
89.5 and 83.4% in D1, D2 and D3, respectively, and was
significantly lower in abundance in D4 (53.1%). Instead,
Bacillaceae, Fusobacteriaceae and Porphyromonadaceae
families were considerably more abundant in D4 (Fig. 2c).
Differences were also observed at genus and species
taxonomic levels (Additional file 2: Table S1). The dom-
inant genera in control samples were Photobacterium
(71%) and Vibrio (19%) (Table 1). After extreme FM/FO
replacement with plan ingredients (D3 diet), the percent-
age of Vibrio drastically diminished (2%) and the domin-
ance of Photobacterium increased, reaching strikingly
high values (81%) in the microbiota of fish fed D3 diet
(Table 1). Butyrate supplementation in D4 fish induced a
partial reversion to the control diet phenotype, with a
decrease in Photobacterium and an increase in Vibrio
genera (Table 1). Moreover, the presence of members of
the genera Bacillus, Fusobacterium and Tannerella sig-
nificantly increased in the intestinal mucus of this fish
group. The proportion of Photobacterium damselae
Table 1 Relative abundance of the dominant genera and
diversity of intestinal microbiota of gilthead sea bream fed
control diet (D1) and test diets (D2, D3 and D4)
Fish group Dominant genera (%) Shannon indexa
Photobacterium Vibrio
D1 71 19 1.53
D2 69 19 1.36
D3 82 2 1.05
D4 44 7 2.27
aShanon’s diversity index integrates both the number of genus and their
relative abundance
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(Phd, formerly Vibrio damsela) significantly increased
from 59% in the control fish to 69% and 81% in D2 and
D3 groups, respectively, going back down to 44% in D4
fish. The proportion and diversity of Vibrio species was
drastically reduced in D3 fish, and only partially recov-
ered in D4 butyrate-supplemented fish compared to D1
and D2. The relative abundances of bacterial genera and
species within each diet group are shown using Krona
analyses (Additional file 3: Figure S2, Additional file 4:
Figure S3, Additional file 5: Figure S4, Additional file 6:
Figure S5).
Principal component analysis (PCA) was used to visual-
ise the relatedness of the samples depending on microbial
community composition (Fig. 3a). The first two compo-
nents, PC1 and PC2, explained 77 and 9.4% of the total
variance, respectively. Variability of replicates within diet
groups was shown using ellipses and clearly displayed a
decrease in variability of microbial communities in re-
sponse to the D3 diet. The largest variability was found in
response to D4 diet. A closer look at the position of the
multivariate centroids (Fig. 3b) revealed that the higher
the FO substitution with VO (D2 < D3), the further the
Fig. 2 Intestinal mucus microbiome composition upon dietary challenges in T2. a Venn diagram depicting unique and shared OTUs among the
different diets. b Stacked bar chart representing the relative abundance of bacterial phyla in the different dietary groups. c Stacked bar chart
showing the relative abundance of the most abundant bacterial families in the different dietary groups
Fig. 3 Principal component analysis (PCA) of the OTU composition from the intestinal mucus microbiome of fish under different dietary
interventions in T2. For clarity, only the centroid of each dietary group is represented. a PCA showing the community centroid positions as well
as the dispersion within each diet group (n = 4 per group, where each sample is a pool of two individual fish) using ellipses. b The same PCA is
represented on a different scale to illustrate the differential position of each dietary group relative to each other
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separation from D1. Interestingly, addition of butyrate in
D4 induced a partial recovery of the control diet pheno-
type evidenced by the reversion in PC1 (77%).
Diet induced changes in the proteomic profile of
intestinal mucus
An initial iTRAQ analysis was performed with eight
pooled samples resulting from the combination of indi-
vidual samples of each intestinal segment (anterior and
posterior) and dietary treatment (D1–D4). In this first
analysis, more than 2000 proteins were unequivocally
identified in samples of intestinal mucus (Additional file 7:
Table S2). The first two components of the PCA ex-
plained 65% of the total variance (45 and 20% for PC1
and PC2, respectively), and this analysis clearly separated
the two intestinal segments along the first principal
component (Fig. 4a). Comparison of anterior and poster-
ior intestine samples revealed that 196 proteins were sig-
nificantly more abundant in one intestine portion, with
139 proteins greater in abundance in the anterior intes-
tine and 57 in the posterior intestine. Among them, 180
proteins (91.8%, 126 from anterior intestine and 54 from
posterior intestine) were eligible for functional pathway
analysis using the Ingenuity IPA software. In the anterior
intestine, 101 over-abundant proteins participated in 26
relevant molecular functions. Among them, the most
representative (Fig. 4b) were related to lipid metabolism
(absorption of cholesterol and triacylglycerol), catabol-
ism of amino acids and energy production (oxidation of
fatty acids). In posterior intestine, 40 over-abundant pro-
teins participated in 25 relevant molecular functions
(Fig. 4c), with special relevance on post-translational
modification (mainly protein deubiquitination) and sev-
eral functions (cellular development, cellular assembly
and organisation, cellular function and maintenance, cell
death and survival, cellular growth and proliferation) re-
lated to cell proliferation. The molecular function of
lipid metabolism was not extensively represented in the
posterior intestine, with only seven proteins with higher
abundance than in the anterior intestine, although it is
interesting to note that two of them (fatty acid binding
protein 6 and phospholipase A2 group 1B) had the high-
est abundance ratio between posterior and anterior in-
testines (33.33 and 5.26, respectively) (Additional file 7:
Table S2).
The diet-mediated effects on intestine pooled samples
were evidenced along the second principal component
of the PCA (Fig. 4a), and were restricted to the anterior
intestine. Thus, a second iTRAQ analysis was performed
only on individual samples of the anterior intestine to
better establish the effect of diets on intestinal mucus
proteome. This second analysis detected 1045 different
proteins with a confidence score higher than 95%
(Additional file 8: Table S3). There were 125 proteins
that were differentially abundant (P < 0.05) for at least
one dietary group (Additional file 9: Table S4). Among
these differentially detected proteins, K-means clustering
supported four major protein patterns, according to the
increase or decrease of abundance with D2 and/or D3
diets in comparison to D1, and the reversion or not to
values closer to D1 in the D4 diet.
Cluster 1 consisted of 57 proteins that were mainly
downregulated by D2 and D3 diets, and most of them
were restored to control values by D4 diet (Fig. 5a). This
cluster was composed of many proteins involved in pro-
tein degradation with molecular functions related to di-
gestion, immune response and cell growth and
differentiation, such as angiotensin-converting enzyme
(ACE), angiotensin-converting enzyme 2 (ACE2),
bleomycin hydrolase, chymotrypsin B, chymotrypsin-like
protease CTRL-1, dipeptidyl peptidase 4, gamma-
interferon-inducible lysosomal thiol reductase, host cell
factor 1, meprin A subunit beta, superoxide dismutase
[Cu-Zn] and ubiquitin fusion degradation protein 1
homologue. Also remarkable was the presence of pro-
teins involved in cholesterol metabolism (chymotrypsin-
like elastase family member 3B, Niemann-Pick C1-like
protein 1), and antioxidant defence (glutathione peroxid-
ase 2). The epithelial mucin 13 (MUC13) was present in
this cluster with downregulation only in D3 and return
to D1 levels with butyrate supplementation (D4).
Proteins with a clear increase in D2 and/or D3 with a re-
turn to control values in D4 fish were represented in clus-
ter 2, and constituted 17 proteins (Fig. 5b). These proteins
were related to cell morphology and epithelial architecture
(importin-7, phosphatidylethanolamine-binding protein 1,
rho GDP-dissociation inhibitor 1, keratin 19, catenin delta
1 and plastin 2) and antioxidant defence (catalase and
glutathione S transferase Mu 3).
Cluster 3 included 27 proteins that decreased in D2
and/or D3 without a clear reversion in D4 (Fig. 5c). This
cluster consisted mostly of proteins related to lipid me-
tabolism and digestion (such as alpha-methylacyl-CoA
racemase, bile salt-activated lipase and apolipoprotein B-
100-like), as well as cell junction processes, like apical
endosomal glycoprotein and cadherin 23.
Cluster 4 comprised 21 upregulated proteins in D2
and/or D3 without a clear reversion by butyrate supple-
mentation in D4 fish (Fig. 5d). Tissue repair was the
most represented physiological process in this group
with a high representation of molecular chaperones
(calreticulin, heat shock cognate 70 kDa protein) and
proteins involved in protein synthesis (60S acidic riboso-
mal protein P1, 60S acidic ribosomal protein P2).
Proteins related to intracellular architecture were also
represented in this cluster (villin 1, adenylyl cyclase
associated protein 1, F-actin-capping protein subunits
alpha 2 and beta).
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Fig. 4 Spatial differences in gilthead sea bream gut mucus proteome in T2. a Principal component analysis of proteomic profiles of pooled samples
from anterior (AI D1, D1 diet; AI D2, D2 diet; AI D3, D3 diet; AI4, D4 diet) and posterior (PI D1, D1 diet; PI D2, D2 diet; PI D3, D3 diet; PI D4, D4 diet)
intestinal segments. Component 1 is represented along X-axis. Component 2 is represented along Y-axis. b Top significant molecular and cellular
functions of proteins over-represented in anterior intestine. c Top significant molecular and cellular functions of proteins over-represented in posterior
intestine. Significance in (b) and (c) is represented as a P value calculated using Benjamini-Hochberg multiple testing correction test. Numbers above
bars represent the number of over-represented proteins for each function
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For proteins of clusters 1–4, PCA analysis showed
that the two first components explained 81% of the
total variance (Fig. 6a). PC1 separated the groups ac-
cording to the inclusion level of FM (D1: 23%; D2, D3,
D4: 3% FM), whereas the distribution of groups along
PC2 was related to the different inclusion level of FO/
VO (D1: 15.6% FO; D2: 6.5% FO, 8.8% VO; D3-D4:
2.5% FO, 13% VO). Accordingly, fish fed D2 and D3 di-
ets moved along PC1 and PC2 when compared to D1
and only along the PC2 when compared to each other.
Butyrate supplementation (D4) helped to restore the in-
testinal mucus proteome of fish fed the control diet evi-
denced by a reversion in both PC axes. When
considering all the proteins as a whole, regardless of
their reversion patterns, some molecular and cellular
functions were highlighted as statistically significant
(determined by Ingenuity pathway analysis (IPA), and
corrected by Benjamini–Hochberg multiple testing
correction) (Fig. 6b). Among the proteins with a rever-
sion pattern to control values in the D4 diet group
(clusters 1 and 2), processes related to protein degrad-
ation, cell signalling, vitamin and mineral metabolism,
amino acid metabolism, molecular transport, and
cellular development and morphology were highly
represented.
Diet induced effects on disease resilience
Diet effect on survival upon bacterial challenge
In trial T1, the average mortality rate of fish fed the bu-
tyrate supplemented diet (D2) after bacterial inoculation
was lower (18.33%) than that of non-supplemented one
(D1) (21.67%). However, this improvement was not sta-
tistically significant. Mortality started 3–4 days after bac-
terial inoculation and prolonged until day 10 post-
injection. No mortality was observed in fish injected
with PBS, regardless of the diet. The inoculated bacter-
ium was always isolated from internal organs of mori-
bund fish in pure culture (Fig. 7).
Diet effect on parasite infection and disease outcome
In trial T3, there were no significant differences in the
prevalence of infection by E. leei, though the values reg-
istered with the experimental vegetable diets (D3) were
slightly higher (Fig. 8a). No significant differences be-
tween groups D1 (control) and D3/D4 (experimental di-
ets) were found in the mean, mode or distribution of
values related to the intensity of infection, i.e. DNA cop-
ies of parasite per gram of intestine (Fig. 8b) or per fish
(data not shown). However, a wider range and a notice-
able cluster of values on the lower end of the intensity
distribution in D4 were observed (Fig. 8b). Thus, when
Fig. 5 K-means clustering heatmaps of nutritionally regulated proteins from anterior intestine mucus in T2. a Cluster 1, with proteins
downregulated by D2 and/or D3 diets and returning to control values in D4. b Cluster 2, with proteins upregulated by D2 and/or D3 diets
and returning to control values in D4. c Cluster 3, with proteins downregulated by D2 and/or D3 diets and no restoration to control values in D4.
d Cluster 4, with proteins upregulated by D2 and/or D3 diets and no restoration to control values in D4
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the intensity of infection data was segmented into three
groups with equal number of individuals, statistically sig-
nificant differences were detected in the mean and the
median between D4 and D1 groups within the lower in-
fection level category (Fig. 8c). The histopathological
study of the different intestinal segments showed a sta-
tistically significant influence of diet on the prevalence
of infection at the anterior intestine (Fig. 8d). Few D1
fish were infected at the anterior intestinal segment,
whereas D3 registered the highest prevalence and D4 an
intermediate value. Only the difference between D1 and
D3 was significant. None of the D1 fish were infected at
the middle intestine, which is the last segment being in-
fected during the chronology/progress of the infection
(Fig. 8d). The number of fish with more than one in-
fected intestinal segment was significantly higher in D3
(66.7%) than in D1 (12.5%), but did not differ statistically
from D4 (40%).
Since clinical signs of enteromyxosis include anorexia,
weight loss and cachexia, growth performance parame-
ters were analysed throughout the trial. No statistical
differences in weight were detected among replicates or
diet groups before the challenge, nor at the intermediate
sampling (5 weeks p.i.), but differences did appear at the
end of the trial (10 weeks p.i.). Specific growth rate
(SGR) decreased in all recipient groups with respect to
their control group, and although no significant differ-
ences were detected, the greatest decrease was observed
in D3, and there was little difference between D4 and
D1 (Fig. 9a). The effect of the infection on growth per-
formance was clearly dependent on the nutritional back-
ground, as the condition factor (CF) of fish exposed to
the parasite decreased significantly due to the infection
in both D1 and D3 recipient fish, whereas almost no im-
pact was found in D4 recipient fish (Fig. 9b).
Discussion
Intestinal microbiota composition and effect of butyrate
supplementation
The fish gastrointestinal (GI) microbiota is a relatively
new field of research, and has only begun to be
Fig. 6 Butyrate effect on anterior intestine mucus proteome in T2.
a Principal component analysis of nutritionally regulated proteins in
anterior intestine mucus samples. Component 1 is represented
along X-axis. Component 2 is represented along Y-axis. b Significant
molecular and cellular functions (IPA) of nutritionally regulated
proteins. Significance is represented as a P value calculated using
Benjamini-Hochberg multiple testing correction test. Numbers in
grey bars represent the number of proteins with a reversion to
control values (clusters 1 and 2 in Fig. 5) in D4 group. Numbers in
white bars represent the number of proteins with no reversion to
control values (clusters 3 and 4) in D4 group
Fig. 7 Effect of butyrate supplementation on survival against
bacterial infection in T1. Cumulative mortality (CM) of gilthead sea
bream fed with a vegetable substitution diet (D1) and the same diet
supplemented with butyrate challenged with Photobacterium
damsela subsp. piscicida
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adequately defined with NGS tools in the past few years
(reviewed in [32, 33, 60, 61]). The analysis of GI micro-
biota (mainly the transient one) in GSB, in wild and
farmed individuals, has been addressed in few recent
works using 16S 454 or Illumina sequencing platforms
[62–64], PCR-denaturing gradient gel electrophoresis
(PCR-DGGE) [65–67] or amplified ribosomal DNA re-
striction analysis and 16S rRNA gene sequencing of cul-
tivable colonies [68]. However, scarce information on
the diversity and role of prokaryotic populations adher-
ing to intestine mucus in fish (autochthonous) is avail-
able, and specifically with respect to host health status.
In this study, we focused on the characterisation of the
autochthonous microbiota in the intestine of cultured
GSB after a dietary intervention using pyrosequencing of
the 16S rRNA gene.
The results revealed that the GSB gut microbiome is
dominated by the phylum Proteobacteria, regardless of diet
(constituting more than 60% relative abundance in all diet
groups examined here), which is in accordance with what
has been described in many teleosts [16, 45, 61, 69–72]
and marine carnivorous fish [73]. The dominance of Pro-
teobacteria in the resident gut microbiota of GSB was also
reported by Kormas et al. [62]. Bacteroidetes and
Fig. 8 Enteromyxum leei infection levels of gilthead sea bream fed three different diets in T3. a Prevalence of infection (%) for each dietary challenged
group (R) by qPCR diagnosis. b Intensity of infection measured by qPCR, the graph shows the mean and standard deviation of the logarithmic
transformation of the number of DNA copies of the parasite per gram of fish intestine and individual scores for each dietary group. c Intensity of
infection segmented in three categories with equal number of individuals. In the low tercile, different letters among diets indicate statistically
significant differences in the mean (ANOVA P < 0.001) and the median (Kruskal-Wallis P = 0.014). d Prevalence of infection (%) per intestinal segment
by histological diagnosis. No statistically significant differences were detected in any of the results except at the anterior intestine (*), in which a
dependency was found between the diet and the number of infected fish, being D1 and D3 significantly different (Yates’ chi-square P = 0.0064)
Fig. 9 Effect of butyrate on growth parameters upon Enteromyxum leei infection in T3. a Specific growth rate (SGR) of challenged (R) fish
represented as mean percentage (+ SEM) relative to each control group for the different dietary groups. b Condition factor (CF) represented as
mean + SEM of each control (open bars) and recipient (solid bars) group for each dietary group. Asterisks represent significant differences
between each pair of control and recipient groups (*P < 0.05, **P < 0.01)
Piazzon et al. Microbiome  (2017) 5:164 Page 13 of 23
Firmicutes appeared in lesser percentages in our study
(from 0.5 to 27.9%), as reported in other fish gut micro-
biota studies [61, 70]. By contrast, in other GSB studies,
the phylum Firmicutes widely dominated the distal gut
transient bacterial community (71%), regardless of the diet-
ary treatment [64], or was well represented in the mixed
gut microbiota (23.7%) [63]. In this latter work, a co-
dominance of Actinobacteria (36.5%) and Proteobacteria
(31.7%) was also observed. These differences show, once
more, that not all datasets are comparable, due to the na-
ture of the samples (intestinal content vs mucus) and the
protocols used to obtain/store them [33, 45]. The transient
microbiota in the intestinal content (allochthonous) of fish
is known to differ from the autochthonous community
[44, 45, 71] and this has been observed in studies on hu-
man gut microbiota [74]. Importantly, the transient micro-
biota may not accurately represent the complexity of the
bacterial consortium living within the fish intestine, and
appear more dependent on the interaction with the diet.
Other possible explanations for the detected differences
could be related to the experimental setup. While the pre-
vious works were performed using closed recirculation sys-
tems with lower water salinity (from 28 to 33‰), shorter
feeding times (from 100 to 154 days) and constant water
temperature (from 22 to 23 °C), our trial (T2) was much
longer (20 months), with an open flow system and with
natural temperature variations that mimicked fish farm
rearing conditions.
Although fish GI microbiota composition is highly in-
fluenced by many factors [34, 71, 75, 76] that make very
difficult to define a global microbiota profile at the host
species level, some authors have tried to define a “core”
gut microbiota, as already explored for humans [77].
Deep sequencing of microbiota from seven intestinal
samples of zebrafish from three different locations sug-
gested a “core” microbiome made of 21 OTUs [78]. This
is not unexpected, since host factors also select which
microbial species can survive. Rawls et al. [79] showed
that transplantation of mouse intestinal microbes (domi-
nated by Firmicutes and Bacteroidetes) into zebrafish,
resulted in the outgrowth of the small number of
Proteobacteria present in the mouse intestine becoming
dominant in 2 weeks in the fish gut. The opposite
occurred in mice colonised with zebrafish intestinal bac-
teria. The “core” gut microbiota of GSB under the study
conditions was composed of 46 OTUs, but further NGS
analyses of a variety wild and farmed GSB are needed to
try to define a global core microbiota of this important
commercial species.
In the current study, the composition of the autoch-
thonous gut microbiota in terms of phylum, family and
genus relative abundance as well as species richness was
clearly affected by the dietary intervention. The extreme
FM/FO replacement (D3 diet) induced a decrease in the
intestinal bacterial diversity and a 22.5- and 4.3-fold in-
crease of Firmicutes and Bacteriodetes phyla, respect-
ively. This trend was further increased by butyrate
addition (D4 diet) (139- and 8.5-fold in Firmicutes and
Bacteroidetes, respectively) which was also responsible
for a 23.2-fold increase of Fusobacteria with respect to
control diet (D1). Thus, fish fed diet D4 with butyrate
supplementation had the most diverse microbiota. In
mice treated with sodium butyrate, Bacteroidetes
decreased, whereas Firmicutes increased [80]. Other
dietary interventions in fish, such as 6% hydrolysed
wheat gluten inclusion in a low-fishmeal diet in Asian
sea bass (Lates calcarifer) [81], or the use of vegetable
proteins from pea and soy instead of FM in rainbow
trout [82], also increased the abundance of Firmicutes in
the gut microbiota. Prebiotic carbohydrate administra-
tion in Siberian sturgeon led to significant and beneficial
shifts in gut-associated bacterial communities towards
butyrate-producing/enhancing bacteria, including lactic
acid bacteria and Clostridium, and therefore increased
the concentration of SCFAs in the intestine [83]. In
humans, Western-style diets, which are low in fibre, de-
crease beneficial Bacteroidetes and increase mucosa-
associated Proteobacteria compared with a high fibre
diet [84]. Thus, it seems we are facing a common trend
across both aquatic and terrestrial gut systems, in which
vegetarian diets or SCFAs increase the relative abun-
dances of Bacteroidetes and Firmicutes, which comprise
butyrate-producing bacterial groups such as Clostridial
cluster XIV and IV and other with probiotic potential as
Bacillus cereus. Therefore, GSB, a carnivorous fish,
seems to adapt part of its autochthonous bacteria to the
diet by increasing the abundance of OTUs typical of
vegetarian fish [73].
Fusobacteria significantly increased in fish fed with the
D4 diet. This group has been recognised to produce bu-
tyric acid as a major product of fermentation [85], and
some species have been associated with diseases in
mammals [86]. Fusobacteria are the most abundant
phylum of the autochthonous normal gut microbiota in
common carp [37], and are also well represented in the
gut microbiota of some lab reared zebrafish [78] and
tropical siluriform fish [87]. Other authors have reported
the presence of Fusobacterium spp. in the gut micro-
biota of three commercial warm-water fish species [88].
F. mortiferum, which represented the 3% of gut micro-
biota of fish fed D4 diet, was the second most commonly
identified genus in the fish species Lepomis macrochirus
in this latter study [88]. These bacteria probably provide
beneficial functions for the host by producing butyrate
from complex polysaccharides.
Within Proteobacteria, VO-based diets favoured the
dominance of Photobacterium species (mainly P. damse-
lae) over Vibrio indicating that fatty acids also play a
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role in such changes. Butyrate supplementation reversed
the decrease of Vibrio only to some extent, following a
restoration trend also observed in the intestinal mucus
proteome. Similarly, diets with partial substitution of FM
with seaweed ingredients induced a significant reduction
of Vibrio species in the intestines of GSB juveniles [66].
Total replacement of FM by vegetable ingredients in
GSB diets produced an increase of the genus Photobac-
terium in the mixed gut microbiota [63]. Photobacterium
damselae strains are high producers of exoenzymes,
helpful for plant diet assimilation [89, 90] which explains
their prevalence in VO diets. By contrast, the most
prevalent phylum in resident gut microbiota of GSB
from wild populations, or fed conventional or organic
diets, were β-Proteobacteria [62] (this study) and not γ-
Proteobacteria. This dominance of γ-Proteobacteria has
been related to vegetable diets [82]. The dietary regime
is likely the best explanation of these differences, but
methodological differences need also consideration, e.g.
DNA extraction was performed from frozen gut tissue at
− 80 °C and this could have affected the bacterial commu-
nity structure [33, 45]. Moreover, specific bacterial consor-
tia can be associated with the distinct selective pressures
imposed within the gut habitat of each host and with the
diet, but also with the time of exposure to the dietary
challenge, as observed in GSB fed probiotics [65].
In humans, reduced faecal microbial diversity is char-
acteristic of diseases such as obesity, type 2 diabetes and
irritable bowel disease [91]. Similarly, the bacterial diver-
sity in the intestine of diseased fish was markedly lower
than in healthy fish [92]. In agreement with our current
results, decreased diversity in gut microbiome has also
been observed in other fish species with different dietary
interventions, such as the combination of probiotic and
prebiotic in sole (Solea senegalensis) [93], the replace-
ment of FO by VO in sablefish (Anoplopoma fimbria)
[16], or soya inclusion in salmon [94]. In GSB, the num-
ber of OTUs decreased from wild to conventionally
reared fish, involving a response of the gut prokaryotic
community to the supplied food as well as possible alter-
ations in food assimilation [62]. However, the diversity
indexes of mixed gut microbiota were not significantly
affected by FM and FO replacement in European sea
bass (Dicentrarchus labrax) [17] or FM replacement in
GSB [63, 64]. In agreement with the current study, the
addition of butyrate also increased the level of biodiver-
sity in transient microbiota of European sea bass [95]
and mouse [80]. On the contrary, sodium butyrate did
not affect significantly the gut microbial communities of
common carp [37]. The partial restoration of the bacter-
ial gut composition to D1 profile and the increase in di-
versity in GSB fed butyrate supplemented diet (D4),
could be considered as reversing signs of the excessive
growth of normal components of GSB gut microbiota
found in D3, such as Photobacterium damsela, which
can act as secondary pathogens of marine animals [96].
Another effect of the vegetable diets was a decrease in
variability, which was also reversed by butyrate addition.
In fact, in humans, the constellations of microbes that
make up an individual’s microbiome are unique, with
only up to 30% conservation of strains shared among
unrelated individuals [97]. In European sea bass, the
high variability of the bacterial profiles among groups
reared under the same conditions was attributed to dif-
ferences in genotypes [71]. In GSB, other authors found
the variability among fish within the same group in the
mixed gut microbiota was higher in fish fed an extreme
vegetable diet than in those fed a standard one [63].
Diet effect on intestinal mucus proteome
The iTRAQ methodology is a gel-free approach that
allows the simultaneous comparison of multiple pro-
teomes, each labelled with specific isobaric mass tags,
and the ratio of the intensities between the different
reporter ions can be used to measure increases or
decreases in the amount of the corresponding peptides
[98]. This technique yields highly reliable quantitative
results for the same protein in different samples, though
it cannot quantify in absolute levels or discriminate
post-translational modifications, and is highly dependent
on homologous protein databases to match and quantify
the obtained MS spectra. In the present trial, this yielded
a high number of intestinal mucus proteins (2217 in
pooled samples) that was reduced to 1045 on individual
samples, since proteins not present in all the individual
analysed samples were not taken into account in the
analysis. Recently, we have also identified more than
2000 proteins in the skin mucus of GSB using 1-DE/MS
approaches [99], when the digested protein fragments
were matched against our protein database with a high
coverage of GSB protein-codifying sequences (more than
15,000 unique sequences in Swissprot). These numbers
are in the same order of magnitude or even higher than
those reported for other mucosal tissues and body fluids
in humans and other animal models [100–102], and in
skin mucus in GSB [103, 104]. The recent use of the
iTRAQ technique to characterise the proteins in bile
and intestinal mucus of Nile tilapia [105] was also able
to discriminate more than 2700 peptide fragments, but
only 319 (corresponding to 179 different proteins) were
properly identified. Whether this relatively low number
reflects the limitations of the use of a non-homologous
protein database in iTRAQ approaches remains unclear.
Our wide-proteome analysis shows the changes in the
composition of anterior-posterior mucus and clearly evi-
dences the functional specialisation along the intestinal
tract of teleost fish. These results are in line with the
data from both zebrafish [106] and Mediterranean
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farmed fish [42, 107] that show a high spatial specialisa-
tion of intestine at the transcriptional and functional
level. Indeed, when comparing iTRAQ profiling of intes-
tinal mucus proteome of GSB with the microarray gene
expression profiling of European sea bass intestine [107],
a high coincidence for the top molecular and cellular
functions was found in both anterior and posterior intes-
tinal segments (11 out of 15 for anterior and 10 out 15
for posterior).
We focused on the anterior intestine when examining
dietary effects upon the intestinal mucus proteome of
GSB because of the results of the first iTRAQ analysis
(anterior and posterior pooled samples from each dietary
condition). A relatively low number of proteins
responded to the diets in the anterior intestine mucus
(121 proteins, 11.5% of the identified proteins). Since all
diets used in this study supported fast growth and feed
conversion efficiency from early life stages to completion
of sexual maturation in four-year old fish [108], the re-
duced impact of vegetable diet formulations on intestinal
mucus composition can be viewed as an indirect evi-
dence of preserved intestinal health. This also applies to
previous wide-transcriptomic studies of intestine in sev-
eral farmed fish, including GSB [109] and Atlantic sal-
mon [110]. However, when a targeted transcriptomic
approach was applied with selected markers of cell dif-
ferentiation and proliferation, intestinal architecture and
permeability, enterocyte mass and epithelial damage,
immune-surveillance and pattern recognition receptors,
the number of differentially expressed genes in the an-
terior intestine of GSB highly reflected the level of FM
and FO replacement [42]. Moreover, in this previous
study, dietary butyrate supplementation was able to re-
verse most of these transcriptionally mediated effects, and
even the changes in the intestinal permeability assessed by
electrophysiology. In the same way, in the present study,
PCA analysis of anterior intestine mucus proteome clearly
showed that the addition of butyrate in D4 could revert
nutritionally regulated proteins to levels much closer to
control diet (D1). This restoration effect is in agreement
with the results on the intestinal microbiome.
The reversion process in the group fed the D4 diet
was observed in more than 60% of the nutritionally reg-
ulated proteins (clusters 1 and 2, 74 proteins), with a
high representation of proteins involved in digestion,
transport, cell signalling and cellular morphology. In
addition to this, the presence of mucin MUC13 in cluster
1 is remarkable, as mucins represent the most abundant
components of the intestinal mucus, and are responsible
for the mucus structure and the protection of intestinal
epithelial surface and membrane proteins from luminal di-
gestive enzymes and pathogens [111–113]. Interestingly,
two other mucins, mucin 2 (MUC2) and mucin 2-like
(MUC2-L), were also present among the identified
proteins in anterior intestine (Additional file 8: Table S3)
and their response to diets was very close (although not
enough to be statistically significant) to that of MUC13,
including the reversion in D4 group.
Previous characterisation of the main mucins expressed
in different GSB tissues [114] indicated the presence of
MUC13, MUC2, MUC2-L and mucin 18 (MUC18) in the
anterior intestine, but gene expression of MUC18 was 30-
to 50-fold lower than that of the other mucins. Thus, the
lack of detection of MUC18 at the protein level here is
not unexpected. It is also of importance that one of the
core proteins associated with mucins, the igGFc-binding
protein (FCGBP), that is usually bound together with
MUC2 in mucus layers [115], showed a similar pattern of
change with the diets, although K-means clustering placed
it in cluster 3.
Diet effects on the abundance of mucins and accom-
panying proteins can have an impact on intestinal
function and integrity. MUC13 plays an important
modulatory role in epithelial response to damage and
infection [116, 117]. Deficiency of MUC2 leads to co-
lonic inflammation [118], and MUC2 expression has
been proven to be stimulated by short chain fatty acids
like butyrate in intestinal epithelial and myofibroblast
cell lines of humans origin [119]. In this regard, down-
regulation of MUC13 and MUC2 in GSB fed D2 and
D3 diets could result in potential inflammation and
pathological problems that can be alleviated by butyrate
supplementation.
A number of proteins involved in protein catabolism
(chymotrypsins, trypsins, bleomycin hydrolase, lactase-
phlorizin hydrolase, proteasome subunits) were less
abundant in mucus samples of fish fed D2 and D3 diets
and recovered the control values in the D4 group
(cluster 1). Proteases are heavily present in the gastro-
intestinal tract, where they exert digestive functions
[120]. ACE and ACE2 proteases were also represented
in cluster 1. ACE is involved in the modulation of intes-
tinal epithelial cells apoptosis and proliferation [121],
while ACE2, involved in intestinal inflammation and in-
nate immunity, is a key regulator of dietary amino acid
homeostasis, an important task for regenerative
responses and repair mechanisms [122–124].
Other proteins that initially were not filtered as nutri-
tionally regulated could be of functional relevance. This
is the case of several molecular chaperones and heat
shock proteins that were detected in the intestinal
mucus (78 kDa glucose-regulated protein, 90 kDa heat
shock protein beta, heat shock 70 kDa protein 4, heat
shock protein 105 kDa) that could be considered as
representative proteins of cluster 4 (up-regulation in
D2 and D3 diets) in addition to heat shock cognate
70 kDa protein. In vivo and in vitro studies have con-
cluded that several nutritional components can affect
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heat shock proteins expression in the gut (as reviewed
in Liu et al. [125]), although it must be noted that this
increase is also a usual symptom of gut inflammation
diseases [126].
Altogether, the use of extreme vegetable diets induced
changes in intestinal mucus proteome that could lead to
an increased susceptibility to pathogens and a partial
loss of intestinal functions. This was especially evident
with the downregulation of mucins that affect the com-
position of the mucus layer and protect the epithelium,
and with the downregulation of proteins related to di-
gestion. Importantly, most of these changes were par-
tially reversed with butyrate addition in D4 diet,
suggesting butyrate/SCFA supplementation as a means
to improve the use of vegetable diets.
Ability of butyrate supplementation to alleviate disease signs
SCFAs, primarily butyrate, not only play a role in energy
homeostasis [127], but also possess antioxidative, anti-
carcinogenic and anti-inflammatory properties that play
an essential role in maintaining gastrointestinal and im-
mune homeostasis in humans and different animal
models [128–131]. However, whether SCFAs impact
antimicrobial host defences remains largely unknown.
Previous studies with human pathogens [132, 133] and
animal (mammals and birds) models [80, 134–137] have
shown the capability of different dietary butyrate formu-
lations to reduce some bacterial and parasitic infections
or their impact on the host. However, the impact of bu-
tyrate on fish health is poorly documented and studies
mainly focus on improvement of immune factors/genes
[37, 138–140]. Studies on the effect of SCFAs against
fish pathogens are very scarce [141, 142].
In the current study, we chose two different types
of pathogens to decipher whether butyrate could
affect host susceptibility. The Gram-negative bacteria
Photobacterium damselae subsp. piscicida was se-
lected because it is the causative agent of photobac-
teriosis, an important disease affecting, among others,
GSB juveniles [56]. Our results show that butyrate
supplementation helps to enhance the survival rate
against this pathogen. Previous studies on rainbow
trout fed β-hydroxy-β-methylbutyrate for 8 weeks
[141] or poly-β-hydroxybutyrate for 6 weeks [142]
also showed improved survival against Aeromonas sal-
monicida and Yersinia ruckeri infections. The de-
crease in mortality found in our study was lower than
those reported for rainbow trout, which can be due
to interspecies differences, different dietary formula-
tions or pathogen aetiology. However, even a modest
improvement in survival (16%) can result in a signifi-
cant economic impact at the animal production
industry scale. The reduced mortality could be medi-
ated by the direct bactericidal effect of sodium
butyrate, by the indirect effect of lower intestinal pH
which favours the growth of beneficial bacteria, or by
improving host immune functions, as described in
broilers [143].
Enteromyxum leei, an enteric myxozoan parasite
(microscopic metazoan relative of Cnidaria), was se-
lected because it progressively invades the paracellular
space of the intestinal epithelium, producing changes at
local and systemic levels [144–146]. It causes important
economic losses in Mediterranean sparid farms [147].
Earlier studies had shown that vegetable oil substitution
can worsen the disease outcome of GSB, when chal-
lenged with E. leei by effluent transmission [148]. To
elucidate this further and to see if this worsening effect
could be alleviated, a diet with high substitution of FM
and FO without (D3) or with supplementation of sodium
butyrate (D4) was tested against a control (D1) using a
highly effective, direct infective route, the anal intub-
ation. The results confirmed that indeed D3 and D4
groups reached a higher prevalence of infection than D1,
though differences were not statistically significant.
Interestingly, however, D4 recipient fish showed indica-
tors of a somehow reduced infection degree. These in-
cluded a less extensive dispersion of parasites along the
intestinal tract (significant lower prevalence of infection
at the anterior intestine than D3 recipient fish), and the
presence of a cluster of low-intensity infected fish in this
group. Furthermore, D4 recipient fish did not show the
typical disease signs of E. leei-infected fish, in which an-
orexia and intestinal damage lead to impaired growth,
cachexia and finally death [59]. Instead, recipient D4
group did not show decreased condition factor as seen
in recipient D1 and D3, or decreased SGR detected in
recipient D3.
Therefore, the main outcome of butyrate supplemen-
tation in D4 recipient fish was that health, in terms of
growth, was not altered, and no obvious disease signs
were observed. Thus, the parasitosis occurred as a “sub-
clinical infection”. While a lower infection prevalence at
the anterior intestine of D4 compared to D3 fish could
partly explain these results (this segment has a major
role of nutrient absorption which could be impaired by
the parasites), this does not seem to be the case in this
experiment because the prevalence of infection at the
anterior intestine in D1 fish was the lowest and this
group did indeed show a significant decrease of CF. A
more likely explanation relates to a more efficient repair
and improvement of the intestinal integrity and function,
which was demonstrated in previous complementary
studies using butyrate-supplemented diets [42]. Indeed,
the D4 diet restored the expression of genes related to
epithelial permeability and structure (tight-junction and
adherence-junction proteins) and mucus production
(which were altered in fish fed D3 diet), and also
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restored the transepithelial electric resistance damaged
by D3 [42]. Similarly, in vitro supplementation of por-
cine small intestinal epithelial cells with sodium butyrate
significantly enhanced mRNA expression of intestinal
mucosal tight junction proteins, which suggests that the
promotion of wound healing by butyrate is related to the
maintenance of the function of the intestinal barrier
[149]. In addition, butyrate-treated mice ameliorated
histological colitis [80]. Overall, the mechanisms behind
this alleviation are complex and multifaceted and remain
to be defined.
Another intervening factor could be the restoration of
the intestinal pro-anti-inflammatory balance, as shown
by the transcriptomic profile of immune related genes of
fish fed D1, D3 and D4 diets, and the inflammatory
histological signs of the intestine [42] and muscle [8].
Extreme plant diets are known to produce inflamma-
tory effects in fish, particularly soybean meal in Atlantic
salmon [19, 150] and other species [40]. However, in
the present trial no such effects were shown for diet D2
[8, 42] indicating that the use of high quality, concen-
trated plant protein sources like soy protein concen-
trate, corn gluten and wheat gluten can successfully
replace FM in GSB diets even at extreme levels. This
can be linked to the lower levels of anti-nutrients and
non-starch polysaccharides in these raw materials com-
pared to their respective meals [82]. On the other hand,
diets D3 and D4 also had a much lower FO content
compared to D1 and D2 and consequently they con-
tained lower dietary levels of essential fatty acids EPA
and DHA. The latter are known to affect fish health
status and immune responses [151] and could explain,
at least partially, the effects shown in this trial. Butyrate
(0.2%), had some mitigating effect on the intestinal in-
flammation signs induced by soybean meal in European
sea bass, though no significant changes were observed
in the expression of several cytokines [40]. The up-
regulation of inflammatory markers in soybean meal-
induced enteropathy [150] was also reversed by adding
bacterial cell wall fractions [152] or a lyophilized live
lactic acid bacterium [153] to the diet. However, little is
known on the effects of butyrate on low FO diets and
the potential interactions with essential fatty acids as
shown in this study. In the current study, such changes
were mainly observed at the anterior intestine of GSB,
which was more responsive to the dietary treatments.
This antero-posterior decreasing gradient could be ex-
plained, at least in part, by the fact that the delivery of
the highest dose of butyrate, even being partially pro-
tected, is supposed to occur preferentially at the anter-
ior intestine segment [42].
In the present study, the concomitant changes de-
tected in the microbiome and the mucus proteome of
D4 intestines could also help to explain the better dis-
ease outcome of these fish. In particular, research in the
last decade in humans and other animal models has con-
vincingly demonstrated that the microbiota is crucial in
order to prime and orchestrate innate and adaptive im-
mune responses and influence barrier function as well as
multiple developmental and metabolic parameters of the
Fig. 10 Integrative diagram showing the main results obtained in the current and previous works [42] when feeding gilthead sea bream with
extreme vegetable diets or supplementing them with sodium butyrate (BP-70 ®Norel). Red arrows indicate increasing effect and green ones
decreasing effect. Black arrows indicate possible relationship to be further explored in future studies
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host. Reciprocally, host reactions and immune responses
instruct the composition of the microbiota [154].
Changes in the balance between commensal and patho-
genic bacteria could result in a different impact of bac-
teria at the epithelial level (the target site of E. leei) or
even affect the development of the parasite. This has
already been demonstrated for an insect-parasite model:
a Trypanosoma cruzi clone changes the microbiota
population in the digestive tract by modulating the host
immune responses and this contributes to parasite de-
velopment in the gut of Rhodnius prolixus [155]. Like-
wise, human intestinal apicomplexan parasites have a
remodelling effect on the gut microbiota profile [156].
Although rapid advances in our understanding of host-
intestinal bacteria interactions have been achieved in fish
[157, 158], the inter-relationship of intestinal micropara-
sites and gut microbiota remains largely unexplored and
future efforts should be made to address this gap. Fur-
ther studies in this fish-parasite model will elucidate
how much the parasite infection alters the gut micro-
biota and the mucosal proteome.
Conclusions
Figure 10 summarises and integrates the current results
with those previously obtained by us using a fish-
parasite model. Opposed forces are driven by dietary
plant ingredients and sodium butyrate supplementation
in GSB diet. On the one hand, vegetable diets induced
high parasite infection levels that provoked drops in
growth performance, inflammation and loss of gut integ-
rity and function, reduction in intestinal microbiota di-
versity and dominance of Photobacterium genus, as well
as changes of gut mucosal proteome with potential det-
rimental effects on intestinal function. On the other
hand, butyrate addition did not prevent the infection,
but avoided growth retardation and decreased inflamma-
tion in challenged fish, as well as restored gut integrity
and function, increased intestinal microbiota diversity
with a higher representation of butyrate-producing bac-
teria and reversed most changes in the gut proteome.
This multifaceted integrative study provides insights on
the pleiotropic effects of a dietary additive on the main-
tenance of intestinal health and disease resilience. The no-
tion that different dietary components can modulate the
microbiota has started to be used therapeutically in
humans [159] and is becoming a major avenue of research
in aquaculture. However, information and understanding
regarding fish gut microbiota still lags behind that of hu-
man and other mammals, including evidence for cause-
effect relationships between gut microbiota and host
physiology. In any case, this study is an important step to-
wards establishing GSB as a powerful model for the devel-
opment of sustainable and healthy fish feeds.
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